DYRK1A and breast cancer: DYRK1A-KO and NT-KO control colon cancer (HCT-116) and breast cancer (MDA-MB-231) cells were serum starved for 24 h to induce quiescence before being processed with the PyroninY/Hoechst 33342 double staining.